The Vanderbilt University Office of Investments administers the endowment fund for the University and Medical Center.
The Vanderbilt University Office of Investments administers the endowment fund for the University and Medical Center. As such and in conjunction with the Investment Committee of the Vanderbilt Board of Trust this office:• Sets asset allocation policy to provide real returns to preserve generational equity.• Selects investment managers according to allocation guidelines.• Monitors investment performance to ensure investment return and policy adherence.Vanderbilt University Endowment Value as of June 30, 2008, is $3.495B.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 4, 2022
Cera
|
Series Unknown | £130M | Elder Care | — |
Jul 6, 2007
NephroGenex
|
Series A | $3.30M | Biotechnology | — |
Vanderbilt University Office of Investments has had 1 exits. Vanderbilt University Office of Investments most notable exits include NephroGenex
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 11, 2014 | NephroGenex | IPO | Biotechnology | Detail |